Delivery Order SPE2DB22D3301-SPE2DB24FZ2PT
Award Date
8/9/24
Potential Completion Date
8/12/24
Potential Value
$1.2K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $1,130.99, is a Delivery Order contract for the supply of CLOBAZAM 2.5 MG/ML SUSPENSION 120ML, a pharmaceutical product. The contract has an ultimate completion date of March 3, 2025 and is a Firm Fixed Price arrangement. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC)...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,119.60, is a Firm Fixed Price Delivery Order for the supply of 4567232687 - CLOBAZAM 2.5 MG/ML SUSPENSION 120ML. The award has an ultimate completion date of February 12, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
This federal contract award, valued at $1,415.28, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4567379879 CLOBAZAM 2.5 MG/ML SUSPENSION 120ML, a pharmaceutical product. The contract is a firm fixed-price delivery order with a completion date of February 26, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division, a major supplier of pharmaceutical products and medical supplies to the U.S. government. The $1,024.26 firm fixed price delivery order is for the supply of 4565123421 - CLOBAZAM 2.5 MG/ML SUSPENSION 120ML. The award is associated with a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at up to...
This federal contract award, valued at $5,962.98, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award covers the delivery of 4567254711 - CLOBAZAM 2.5 MG/ML SUSPENSION 120ML, a pharmaceutical product, to support military healthcare programs. The contract is a Firm Fixed Price Delivery Order, with a completion date of February 13, 2025. This award is part of a larger Indefinite Delivery...
This is a $1,294.26 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office Division. The contract is for the supply of 4565218366 - CLOBAZAM 2.5 MG/ML SUSPENSION 120ML, with a period of performance through July 23, 2024. AmerisourceBergen, a major pharmaceutical distributor, has been awarded several federal contracts and Indefinite Delivery Contracts (IDCs) by the DLA and other agencies to provide a wide...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,984.60, is for the supply of 4562816595 - CLOBAZAM 2.5 MG/ML SUSPENSION 120ML, a pharmaceutical product. The contract has a ceiling value of $3,984.60 and a completion date of November 15, 2023. This is not a set-aside contract. AmerisourceBergen holds a significant Indefinite...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) and has a ceiling value of $1,555.93. The contract is a Delivery Order for the procurement of CLOBAZAM 10 MG TABLET 100S, with a completion date of December 10, 2024. The contract is a Firm Fixed Price arrangement and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is the prime contractor and holds a...
This federal contract award, valued at $3,111.86, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of CLOBAZAM 10 MG TABLET 100S, a pharmaceutical product, and is designated as a Firm Fixed Price Delivery Order with a completion date of February 21, 2025. The contract is not associated with a set-aside program. Amerisourcebergen Drug Corp holds a significant...
This federal contract award, valued at $5,104.61, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of CLOBAZAM 10 MG TABLET 100S, a pharmaceutical product. The contract has an ultimate completion date of March 25, 2025 and is a Firm Fixed Price Delivery Order. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant...